{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:17:47Z","timestamp":1761535067468,"version":"build-2065373602"},"reference-count":74,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T00:00:00Z","timestamp":1667433600000},"content-version":"vor","delay-in-days":2163,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1111\/jth.13515","type":"journal-article","created":{"date-parts":[[2016,9,26]],"date-time":"2016-09-26T04:03:03Z","timestamp":1474862583000},"page":"2430-2445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["A quantitative systems pharmacology model of blood coagulation network describes in\u00a0vivo biomarker changes in non\u2010bleeding subjects"],"prefix":"10.1016","volume":"14","author":[{"given":"D.","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7225-1317","authenticated-orcid":false,"given":"S.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.W.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Heatherington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Vicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Hua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13515_bb0010","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1615\/CritRevEukarGeneExpr.v7.i3.40","article-title":"The regulation of clotting factors","volume":"7","author":"Kalafatis","year":"1997","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1111\/jth.13515_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/IAE.0b013e31819091dc","article-title":"Recent advances in haemostasis and thrombosis","volume":"29","author":"Vine","year":"2009","journal-title":"Retina"},{"key":"10.1111\/jth.13515_bb0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1046\/j.1365-2516.1999.00300.x","article-title":"Incidence of inhibitors in haemophilia\u00a0A patients \u2013 a review of recent studies of recombinant and plasma\u2010derived factor\u00a0VIII concentrates","volume":"5","author":"Scharrer","year":"1999","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13515_bb0025","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.1111\/j.1365-2516.2010.02352.x","article-title":"First 20\u00a0years with recombinant FVIIa (NovoSeven)","volume":"17","author":"Hedner","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13515_bb0030","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1538-7836.2012.04793.x","article-title":"Mechanisms and monitoring of bypassing agent therapy","volume":"10","author":"Hoffman","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0035","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.1182\/blood-2014-05-576892","article-title":"In\u00a0vitro evidence of a tissue factor\u2010independent mode of action of recombinant factor\u00a0VIIa in hemophilia","volume":"124","author":"Augustsson","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pcbi.1000950","article-title":"Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood","volume":"6","author":"Chatterjee","year":"2010","journal-title":"PLoS Comput Biol"},{"key":"10.1111\/jth.13515_bb0045","doi-asserted-by":"crossref","first-page":"18322","DOI":"10.1074\/jbc.M201173200","article-title":"A model for the stoichiometric regulation of blood coagulation","volume":"277","author":"Hockin","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13515_bb0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/clpt.2009.87","article-title":"A comprehensive model for the humoral coagulation network in humans","volume":"86","author":"Wajima","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/jth.13515_bb0055","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/psp4.50","article-title":"Using a systems pharmacology model of the blood coagulation network to predict the effects of various therapies on biomarkers","volume":"4","author":"Nayak","year":"2015","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1111\/jth.13515_bb0060","doi-asserted-by":"crossref","first-page":"e949","DOI":"10.1111\/j.1365-2516.2011.02492.x","article-title":"Monitoring rFVIIa 90\u00a0mug\u00a0kg(\u2010)(1) dosing in haemophiliacs: comparing laboratory response using various whole blood assays over 6\u00a0h","volume":"17","author":"Brophy","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13515_bb0065","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1365-2516.2007.01516.x","article-title":"A randomized, double\u2010blind trial demonstrating bioequivalence of the current recombinant activated factor\u00a0VII formulation and a new robust 25\u00a0degrees\u00a0C stable formulation","volume":"13","author":"Bysted","year":"2007","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13515_bb0070","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/01.mbc.0000169218.15926.34","article-title":"A study of the pharmacokinetics and safety of recombinant activated factor\u00a0VII in healthy Caucasian and Japanese subjects","volume":"16","author":"Fridberg","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13515_bb0075","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00001721-199308000-00001","article-title":"Safety and initial clinical efficacy of three dose levels of recombinant activated factor\u00a0VII (rFVIIa): results of a phase\u00a0I study","volume":"4","author":"Macik","year":"1993","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/jth.13515_bb0080","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2516.2011.02498.x","article-title":"Pharmacokinetics and safety of a 270\u00a0mcg\u00a0kg\u20101 dose of room temperature stable recombinant activated factor\u00a0VII in patients with haemophilia","volume":"17","author":"Morfini","year":"2011","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13515_bb0085","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1538-7836.2008.03253.x","article-title":"Evaluation of the safety and pharmacokinetics of a fast\u2010acting recombinant FVIIa analogue, NN1731, in healthy male subjects","volume":"7","author":"Moss","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0090","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2516.2005.01160.x","article-title":"Pharmacokinetics, thrombogenicity and safety of a double viral inactivated factor\u00a0IX concentrate compared with a prothrombin complex concentrate","volume":"11","author":"Ruiz\u2010Saez","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13515_bb0095","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood.V124.21.2824.2824","article-title":"Pharmacokinetics of multiple doses of rFVIIa in patients with hemophilia with and without inhibitors (Abstract)","author":"Stenmo","year":"2014","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0100","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/1076029607309176","article-title":"Elevated levels of prothrombin fragment\u00a01\u00a0+\u00a02 indicate high risk of thrombosis","volume":"14","author":"Ota","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1111\/jth.13515_bb0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.wnl.0000223349.97278.e0","article-title":"Plasma d\u2010dimer predicts poor outcome after acute intracerebral hemorrhage","volume":"67","author":"Delgado","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/jth.13515_bb0110","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1309\/JM5E-QQAD-XN79-00PY","article-title":"The role of D\u2010dimer in the diagnosis of venous thromboembolism","volume":"33","author":"Schreiber","year":"2002","journal-title":"Lab Med"},{"key":"10.1111\/jth.13515_bb0115","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1161\/01.CIR.103.21.2555","article-title":"Ability of recombinant factor\u00a0VIIa to generate thrombin during inhibition of tissue factor in human subjects","volume":"103","author":"Friederich","year":"2001","journal-title":"Circulation"},{"key":"10.1111\/jth.13515_bb0120","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2004-09-3567","article-title":"Tissue factor activity in whole blood","volume":"105","author":"Butenas","year":"2005","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0125","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13515_bb0130","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1055\/s-0037-1613831","article-title":"Haemostatic and lipid determinants of prothrombin fragment\u00a0F1.2 and D\u2010dimer in plasma","volume":"83","author":"MacCallum","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0135","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1538-7836.2011.04549.x","article-title":"Recombinant factor\u00a0VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial","volume":"10","author":"de Paula","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0140","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1538-7836.2012.04667.x","article-title":"Phase\u00a0I, randomized, double\u2010blind, placebo\u2010controlled, single\u2010dose escalation study of the recombinant factor\u00a0VIIa variant BAY\u00a086\u20106150 in hemophilia","volume":"10","author":"Mahlangu","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/jth.12864","article-title":"The Explorer I. Safety and pharmacokinetics of anti\u2010TFPI antibody (concizumab) in healthy volunteers and patients with hemophilia: a randomized first human dose trial","volume":"13","author":"Chowdary","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1023\/A:1018835706759","article-title":"A mathematical model of the background state of the blood coagulation system","volume":"376","author":"Obraztsov","year":"2001","journal-title":"Dokl Biochem Biophys"},{"key":"10.1111\/jth.13515_bb0155","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1182\/blood-2010-09-311035","article-title":"Prothrombin activation on the activated platelet surface optimizes expression of procoagulant activity","volume":"117","author":"Wood","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0160","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1538-7836.2010.04152.x","article-title":"Recombinant human factor\u00a0VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients","volume":"9","author":"Agerso","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0165","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1049\/iet-syb.2011.0015","article-title":"Sensitivity analysis approaches applied to systems biology models","volume":"5","author":"Zi","year":"2011","journal-title":"IET Syst Biol"},{"key":"10.1111\/jth.13515_bb0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1182\/blood.V80.1.25.25","article-title":"Measurement of basal levels of factor\u00a0VIIa in hemophilia\u00a0A and B patients","volume":"80","author":"Wildgoose","year":"1992","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0175","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1182\/blood.V86.8.3021.3021","article-title":"Determinants of plasma factor\u00a0VIIa levels in humans","volume":"86","author":"Eichinger","year":"1995","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0180","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1182\/blood.V79.8.2039.2039","article-title":"Factor\u00a0IXa\u2013factor\u00a0VIIIa\u2010cell surface complex does not contribute to the basal activation of the coagulation mechanism in\u00a0vivo","volume":"79","author":"Bauer","year":"1992","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF02309851","article-title":"Purpura fulminans in severe congenital protein\u00a0C deficiency: monitoring of treatment with protein\u00a0C concentrate","volume":"155","author":"M\u00fcller","year":"1996","journal-title":"Eur J Pediatr"},{"key":"10.1111\/jth.13515_bb0190","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1055\/s-0038-1650259","article-title":"Elevated levels of prothrombin activation fragment\u00a01\u00a0+\u00a02 in plasma from patients with heterozygous Arg506 to Gln mutation in the factor\u00a0V gene (APC\u2010resistance) and\/or inherited protein\u00a0S deficiency","volume":"75","author":"Z\u00f6ller","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0195","doi-asserted-by":"crossref","first-page":"20627","DOI":"10.1074\/jbc.M000209200","article-title":"Examining thrombin hydrolysis of the factor\u00a0XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor\u00a0XIII V34L mutation","volume":"275","author":"Trumbo","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13515_bb0200","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1021\/bi961636z","article-title":"Crosslinking kinetics of the human transglutaminase, factor\u00a0xiii [a2], acting on fibrin gels and \u03b3\u2010chain peptides","volume":"36","author":"Lewis","year":"1997","journal-title":"Biochemistry"},{"key":"10.1111\/jth.13515_bb0205","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1432-1033.1988.tb14077.x","article-title":"The influence of fibrin (ogen) fragments on the kinetic parameters of the tissue\u2010type plasminogen\u2010activator\u2010mediated activation of different forms of plasminogen","volume":"174","author":"Nieuwenhuizen","year":"1988","journal-title":"Eur J Biochem"},{"key":"10.1111\/jth.13515_bb0210","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1538-7836.2007.02426.x","article-title":"The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease","volume":"5","author":"Kim","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0215","doi-asserted-by":"crossref","first-page":"4962","DOI":"10.1074\/jbc.274.8.4962","article-title":"Down\u2010regulation of monocyte tissue factor mediated by tissue factor pathway inhibitor and the low density lipoprotein receptor\u2010related protein","volume":"274","author":"Hamik","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13515_bb0220","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1172\/JCI106095","article-title":"Human prothrombin metabolism in normal man and in hypocoagulable subjects","volume":"48","author":"Shapiro","year":"1969","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13515_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2431-7-8","article-title":"A neonatal presentation of factor\u00a0V deficiency: a case report","volume":"7","author":"Chingale","year":"2007","journal-title":"BMC Pediatr"},{"key":"10.1111\/jth.13515_bb0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1182\/blood.V60.1.59.59","article-title":"Radioimmunoassay of factor\u00a0V in human plasma and platelets","volume":"60","author":"Tracy","year":"1982","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0235","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1365-2516.2008.01844.x","article-title":"Factor\u00a0VII deficiency: defining the clinical picture and optimizing therapeutic options","volume":"14","author":"Lapecorella","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13515_bb0240","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2125.2007.03030.x","article-title":"Overview of the human pharmacokinetics of recombinant activated factor\u00a0VII","volume":"65","author":"Klitgaard","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/jth.13515_bb0245","doi-asserted-by":"crossref","first-page":"815","DOI":"10.2165\/00003088-200140110-00003","article-title":"Pharmacokinetics of coagulation factors","volume":"40","author":"Bj\u00f6rkman","year":"2001","journal-title":"Clin Pharmacokinet"},{"year":"2014","series-title":"Clinical Pathology Board Review","author":"Spitalnik","key":"10.1111\/jth.13515_bb0250"},{"key":"10.1111\/jth.13515_bb0255","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1182\/blood-2010-08-300756","article-title":"Zymogen\u2010like factor\u00a0Xa variants restore thrombin generation and effectively bypass the intrinsic pathway in\u00a0vitro","volume":"117","author":"Bunce","year":"2011","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0260","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1365-2516.2000.00053.x","article-title":"Factor\u00a0XI deficiency and its management","volume":"6","author":"Bolton\u2010Maggs","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/jth.13515_bb0265","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1055\/s-0038-1650621","article-title":"Inactivation of factor\u00a0Xia in\u00a0vivo: studies in chimpanzees and in humans","volume":"76","author":"Wuillemin","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0270","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1172\/JCI111066","article-title":"Synthesis and release of Hageman factor (factor\u00a0XII) by the isolated perfused rat liver","volume":"72","author":"Saito","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13515_bb0275","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI111360","article-title":"Inactivation of factor\u00a0XII active fragment in normal plasma. Predominant role of C\u20101\u2010inhibitor","volume":"73","author":"de Agostini","year":"1984","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13515_bb0280","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood-2005-02-0788","article-title":"Safety and pharmacokinetics of recombinant factor\u00a0XIII\u2010A2 administration in patients with congenital factor\u00a0XIII deficiency","volume":"108","author":"Lovejoy","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0285","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.1871","article-title":"Tissue factor pathway inhibitor: structure, biology and involvement in disease","volume":"208","author":"Lwaleed","year":"2006","journal-title":"J Pathol"},{"key":"10.1111\/jth.13515_bb0290","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V78.2.387.387","article-title":"Plasma antigen levels of the lipoprotein\u2010associated coagulation inhibitor in patient samples","volume":"78","author":"Novotny","year":"1991","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0295","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2362.1977.tb01566.x","article-title":"Metabolism of antithrombin\u00a0III (heparin cofactor) in man: effects of venous thrombosis and of heparin administration","volume":"7","author":"Collen","year":"1977","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/jth.13515_bb0300","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1055\/s-0038-1646768","article-title":"Determination of human thrombin\u2013antithrombin\u00a0III complex in plasma with an enzyme\u2010linked immunosorbent assay","volume":"59","author":"Pelzer","year":"1988","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13515_bb0305","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.toxicon.2008.08.013","article-title":"A model for venom\u2010induced consumptive coagulopathy in snake bite","volume":"52","author":"Tanos","year":"2008","journal-title":"Toxicon"},{"key":"10.1111\/jth.13515_bb0310","doi-asserted-by":"crossref","first-page":"15815","DOI":"10.1016\/S0021-9258(19)37661-6","article-title":"The structure and function of mouse thrombomodulin. Phorbol myristate acetate stimulates degradation and synthesis of thrombomodulin without affecting mRNA levels in hemangioma cells","volume":"263","author":"Dittman","year":"1988","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13515_bb0315","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0168-8227(90)90044-T","article-title":"Plasma thrombomodulin concentration in diabetes mellitus","volume":"10","author":"Oida","year":"1990","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/jth.13515_bb0320","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJM198710153171604","article-title":"Absence of thrombosis in subjects with heterozygous protein\u00a0C deficiency","volume":"317","author":"Miletich","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.13515_bb0325","unstructured":"Murphy JE, American Society of Health\u2010System Pharmacists. Clinical pharmacokinetics, 5th edn. Bethesda, MD: the American Society of Health\u2010Systems Pharmacists, Inc., 2012."},{"key":"10.1111\/jth.13515_bb0330","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood.V79.9.2340.2340","article-title":"Direct detection of activated protein\u00a0C in blood from human subjects","volume":"79","author":"Gruber","year":"1992","journal-title":"Blood"},{"key":"10.1111\/jth.13515_bb0335","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.2174\/1381612819666131230131454","article-title":"Phase\u00a01 safety, tolerability and pharmacokinetics of 3K3A\u2010APC in healthy adult volunteers","volume":"19","author":"Lyden","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1111\/jth.13515_bb0340","doi-asserted-by":"crossref","first-page":"43983","DOI":"10.1074\/jbc.M304239200","article-title":"The relative priority of prekallikrein and factors\u00a0XI\/XIa assembly on cultured endothelial cells","volume":"278","author":"Mahdi","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13515_bb0345","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1309\/LM5VS8FIFRF1OHCT","article-title":"A challenging diagnosis of homozygous prekallikrein deficiency during the preoperative evaluation of an infant with intractable seizures: a literature review of surgical management in this disorder","volume":"41","author":"Unal","year":"2010","journal-title":"Lab Med"},{"key":"10.1111\/jth.13515_bb0350","first-page":"514","article-title":"In\u00a0vivo catabolism of human kallikrein\u2010binding protein and its complex with tissue kallikrein","volume":"119","author":"Xiong","year":"1992","journal-title":"J Lab Clin Med"},{"key":"10.1111\/jth.13515_bb0355","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1136\/jcp.34.9.979","article-title":"Concentration of plasminogen and antiplasmin in plasma and serum","volume":"34","author":"Cederholm\u2010Williams","year":"1981","journal-title":"J Clin Pathol"},{"key":"10.1111\/jth.13515_bb0360","first-page":"1","article-title":"Criteria for specific measurement of plasminogen (enzymatic; procedure) in human plasma","volume":"19","author":"Sidelmann","year":"2000","journal-title":"eJIFCC"},{"key":"10.1111\/jth.13515_bb0365","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/0002-9149(86)90192-X","article-title":"High\u2010dose, brief\u2010duration intravenous infusion of streptokinase in acute myocardial infarction: description of effects in the circulation","volume":"57","author":"Mentzer","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.13515_bb0370","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1172\/JCI112040","article-title":"Elevated factor\u00a0Xa activity in the blood of asymptomatic patients with congenital antithrombin deficiency","volume":"76","author":"Bauer","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1111\/jth.13515_bb0375","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/01.CIR.96.3.761","article-title":"Clearance of tissue plasminogen activator (TPA) and TPA\/plasminogen activator inhibitor type\u00a01 (PAI\u20101) complex relationship to elevated TPA antigen in patients with high PAI\u20101 activity levels","volume":"96","author":"Chandler","year":"1997","journal-title":"Circulation"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13515","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13515","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622025296?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622025296?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13515\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:13:33Z","timestamp":1761534813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622025296"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":74,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1538783622025296"],"URL":"https:\/\/doi.org\/10.1111\/jth.13515","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A quantitative systems pharmacology model of blood coagulation network describes in\u00a0vivo biomarker changes in non\u2010bleeding subjects","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}